ProPhase Labs, Inc. Common Stock Dividends Paid
ProPhase Labs, Inc. (PRPH) had Common Stock Dividends Paid of $4.70 million as of 2022-05-25, per its 10-K filed 2023-03-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfDividendsCommonStock · last filed 2024-03-29
- 2022-05-25: Payments of Ordinary Dividends, Common Stock $4.70M.
- 2022-05-09: Payments of Ordinary Dividends, Common Stock $4.70M.
- 2022-03-01: Payments of Ordinary Dividends, Common Stock $4.60M.
- 2022-02-14: Payments of Ordinary Dividends, Common Stock $4.60M.
| Period end | Payments of Ordinary Dividends, Common Stock | Payments of Ordinary Dividends, Common Stock 0 month |
|---|---|---|
| 2022-05-25 | $4.70M 10-K · filed 2023-03-29 | |
| 2022-05-09 | $4.70M 10-K · filed 2024-03-29 | |
| 2022-03-01 | $4.60M 10-K · filed 2023-03-29 | |
| 2022-02-14 | $4.60M 10-K · filed 2024-03-29 | |
| 2021-06-03 | $4.50M 10-K · filed 2023-03-29 | |
| 2019-12-12 | $2.90M 10-K · filed 2021-03-31 | |
| 2019-01-24 | $2.90M 10-Q · filed 2019-11-12 | |
| 2018-09-05 | $11.70M 10-Q · filed 2019-11-12 | |
| 2018-05-07 | $11.70M 10-Q · filed 2019-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |